Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors. Bsteh G, Feige J, Ehling R, Auer M, Hegen H, Di Pauli F, Deisenhammer F, Reindl M, Berger T Mult Scler. 2017 Aug; 23(9):1241-1248. PMID: 27765877. Abstract CommentRecommendBookmarkWatch
